Cancer Biology & Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2020-08-12 ms8000000396508058

有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的

138 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2021-01-17 1322004234m

审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0
经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。

122 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2020-11-18 silent111

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤血管发生
经验分享：大家好，最近有人投稿这个杂志么？
我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！
感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。
希望有投稿的交流一下。大家觉得这个杂志值得等么？

147 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2022-12-20 APPLE4328 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤基础研究
经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！
版面费10000RMB.

73 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2022-04-19 120583eam68(暂无昵称)

审稿速度:6.0 | 投稿命中率:5.0
经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？

68 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

引言三段式指的是什么?

81 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2018-10-17 Harriet3904

投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了

265 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2020-06-02 lovetcm

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;乳腺癌;肿瘤机制
经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！

119 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

引言一般是三段式么？

72 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=808244, encodeId=e2d08082442a, content=有没有近期投稿有经验的前辈，给个时间线和状态呀？最好是综述方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=ms8000000396508058, createdTime=Wed Aug 12 18:44:28 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917306, encodeId=ed3691e30654, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:1500.0 经验分享：整体感觉，杂志速度中等偏慢，投稿后2个半月给小修，10天返修后1个月接收！从投稿到接收花了4个月。每次等待都焦急无比，但是今年升了1区，感觉还是值得的，审稿人给的意见也比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 17 04:07:53 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900226, encodeId=f57c900226d6, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤血管发生 经验分享：大家好，最近有人投稿这个杂志么？ 我2020.10.16投稿的，到现在（11.18）一直是awaiting admin processing，根本没有往下走！！！ 感觉这个杂志非常慢。中国的效率也太慢了。几次有撤稿的冲动。 希望有投稿的交流一下。大家觉得这个杂志值得等么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Wed Nov 18 16:35:14 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106776, encodeId=510f2106e76d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤基础研究 经验分享：投了一篇综述，初审一个月让大修，5个review，要求不低，其中有一个review提了10个问题，因为涉及的一部分内容正好是这个专家的方向，所以提了几个还是有意义的问题。然后一个半月修回，后面有反复修回2次。所以整体来看，审稿专家还是很严苛的，有一些水平不错的专家。从投稿到接收整4个半月。周期漫长！ 版面费10000RMB., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/peh07oFcLySxu44NrXHjVW0d6akUbdmw7bSRcGBmSOGVPpDWyGMouqXEHp3iayImyvkKS5FtqTEhR2UTGcLPl7g/132, createdBy=7c9d2380662, createdName=APPLE4328, createdTime=Tue Dec 20 09:54:53 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1212707, encodeId=720a1212e077e, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：杂志和主编眼光太高了，本来就是二流杂志，非得上科协T1分级，有什么意义吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aa32173277, createdName=120583eam68(暂无昵称), createdTime=Tue Apr 19 22:55:07 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106922, encodeId=a41911069223b, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562109, encodeId=0bd55621091e, content=投稿已经3.5月，除了一个月之后变为peer review，后面就再也没有更新状态，慢，慢，简直太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/16/b76cec4b25318b42b285243fe6b7fcc8.jpg, createdBy=08c81681626, createdName=Harriet3904, createdTime=Wed Oct 17 23:05:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601148, encodeId=fe1360114878, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;乳腺癌;肿瘤机制 经验分享：更新：在2020年6月份公布的IF中，Cancer Biology & Medicine的IF很可能将超过6分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 02 09:43:43 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106921, encodeId=4ae411069216a, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061287, encodeId=12e8106128e70, content=偏重的研究方向：肿瘤 经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Sun Oct 17 19:59:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]

2021-10-17 水逆退散～

偏重的研究方向：肿瘤
经验分享：Mark一下，10-12投稿，目前Awaiting Admin Processing，不知道什么时候分配AE

91 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务